3 Stocks That May Be Trading At A Discount Of Up To 45.8% Below Intrinsic Value Estimates
In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 20%, with earnings expected to grow by 18% per annum in the coming years. In this context of overall growth and stability, identifying stocks that may be trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Victoria's Secret (VSXY) | $78.36 | $151.62 | 48.3% |
| Q2 Holdings (QTWO) | $51.83 | $103.06 | 49.7% |
| Lazard (LAZ) | $41.41 | $82.45 | 49.8% |
| Klaviyo (KVYO) | $16.91 | $33.27 | 49.2% |
| Inter & Co (INTR) | $5.82 | $11.51 | 49.4% |
| Genuine Parts (GPC) | $125.62 | $247.98 | 49.3% |
| Caledonia Mining (CMCL) | $17.76 | $33.71 | 47.3% |
| Betterware de MéxicoP.I. de (BWMX) | $18.25 | $36.34 | 49.8% |
| Beacon Financial (BBT) | $30.19 | $59.59 | 49.3% |
| Amaroq (AMRQ.F) | $1.155 | $2.24 | 48.3% |
Here we highlight a subset of our preferred stocks from the screener.
BioLife Solutions (BLFS)
Overview: BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy industry globally, with a market cap of $1.38 billion.
Operations: The company generates revenue from its Biopreservation Tools segment, amounting to $101.66 million.
Estimated Discount To Fair Value: 25%
BioLife Solutions is trading at US$28.18, below its estimated future cash flow value of US$37.59, suggesting undervaluation based on cash flows. The company's earnings are forecast to grow 50.38% annually, with revenue expected to increase by 17.7% per year—outpacing the broader U.S. market growth rate of 13%. Recent inclusion in multiple Russell Value Benchmarks highlights its growing recognition among investors seeking value opportunities in the market.
- Upon reviewing our latest growth report, BioLife Solutions' projected financial performance appears quite optimistic.
- Click to explore a detailed breakdown of our findings in BioLife Solutions' balance sheet health report.
Mission Produce (AVO)
Overview: Mission Produce, Inc. is involved in the sourcing, farming, packaging, marketing, and distribution of avocados, mangoes, and blueberries to various customers globally and has a market cap of approximately $1.18 billion.
Operations: The company's revenue segments include $92.80 million from blueberries, $126.90 million from international farming, and $1.13 billion from marketing and distribution.
Estimated Discount To Fair Value: 12.1%
Mission Produce trades at US$13.33, below its estimated future cash flow value of US$15.17, indicating potential undervaluation. Despite recent losses and shareholder dilution, earnings are forecast to grow significantly at 82.3% annually, though revenue growth is expected to lag slightly behind market averages. Recent acquisition of Calavo Growers may enhance strategic positioning, while a new share repurchase program aims to capitalize on perceived undervaluation by buying back up to US$100 million in stock over 36 months.
- Our growth report here indicates Mission Produce may be poised for an improving outlook.
- Click here and access our complete balance sheet health report to understand the dynamics of Mission Produce.
OceanFirst Financial (OCFC)
Overview: OceanFirst Financial Corp. is the bank holding company for OceanFirst Bank N.A., with a market cap of approximately $1.85 billion.
Operations: OceanFirst Bank N.A. generates revenue primarily through its Community Banking Services, amounting to $396.65 million.
Estimated Discount To Fair Value: 45.8%
OceanFirst Financial, trading at US$19.11, is valued significantly below its estimated future cash flow value of US$35.23. The company's revenue and earnings are forecast to grow rapidly at 34.3% and 54.5% annually, respectively, outpacing the broader U.S. market growth rates. Recent inclusion in several Russell indices may enhance visibility, while the merger with Flushing Financial could bolster strategic capabilities despite past shareholder dilution concerns and modest net income decline in recent quarters.
- Insights from our recent growth report point to a promising forecast for OceanFirst Financial's business outlook.
- Dive into the specifics of OceanFirst Financial here with our thorough financial health report.
Next Steps
- Click this link to deep-dive into the 140 companies within our Undervalued US Stocks Based On Cash Flows screener.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com